The Head of Emergency Preparedness at the World Health Organization is hailing “good news” about the outcomes of two VOCID-19 vaccine candidates in early trials, but warns that “there is a long way to go.” “We need to move into larger-scale real-world trials now,” Dr. Michael Ryan told reporters at a news conference in Geneva.
“But it is good to see more data and more products moving into this very important phase of the discovery of vaccines.” Ryan’s remarks came as scientists at Oxford University, in a paper published in The Lancet, said that their experimental vaccine had been shown to cause a protective immune response in hundreds of people who received the shot.
Chinese researchers have published a study in the medical journal on their experimental vaccine, using a methodology similar to that used by the Oxford team, which documented an immune response. Ryan reported that there are 23 CAVID-19 candidate vaccines in clinical development, but only one has provided Phase 1 clinical results by Monday. (AP) ANSA.